Bristol-Myers’ Evotaz gets European approval to treat HIV-1 infection

Bristol-Myers’ Evotaz gets European approval to treat HIV-1 infection Bristol-Myers Squibb has received approval from the European Commission for Evotaz, a fixed-dose combination of atazanavir and cobicistat, to treat HIV-1 Infection in adults. Evotaz (atazanavir 300mg and cobicistat 150mg) tablets are approved for use in combination with other antiretroviral agents to treat HIV-1 infected adults without known mutations associated with ... Read More »

Finding Happiness

Finding Happiness Once a group of 50 people was attending a seminar. Suddenly the speaker stopped and started giving each person a balloon. Each one was asked to write his/her name on it using a marker pen. Then all the balloons were collected and put in another room. Now these delegates were let in that room and asked to find ... Read More »

Chemotherapeutic coatings enhance tumour-frying nanoparticles: Study

Chemotherapeutic coatings enhance tumour-frying nanoparticles: Study The photothermal therapy is already being tested for several types of cancers in clinical trials conducted by Nanospectra Biosciences Researchers at Duke University have devised a method for making a promising nanoscale cancer treatment even more deadly to tumours. The invention allows an extremely thin layer of hydrogels (think contact lenses) to be deposited on ... Read More »

Union Minister of Chemicals and Fertilisers launches pharma price data bank

Union Minister of Chemicals and Fertilisers launches pharma price data bank Pharma price data bank is an integrated pharmaceutical database management system, managed and operated by National Pharmaceutical Pricing Authority The Union Minister of Chemicals and Fertilisers, Ananth Kumar launched pharma price data bank. It is an integrated pharmaceutical database management system, managed and operated by National Pharmaceutical Pricing Authority (NPPA). ... Read More »

The Lost Camel

The Lost Camel Once two merchants lost a camel. They met a traveller and asked him if he had seen it. The man replied he had not.” But was your camel blind in the right eye?” Said he to them. “Yes, he was”, replied the merchants. “Was it lame in one left foot?” The man asked again. “Cer­tainly it was”, ... Read More »

AGTC Catapults Premarket on $1 Billion+ Eye Disease Pact With Biogen

AGTC Catapults Premarket on $1 Billion+ Eye Disease Pact With Biogen CAMBRIDGE, Mass. — Biogen, Inc. and AGTC (AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene therapies for the treatment of rare eye diseases, entered into an agreement worth more than $1 billion to develop gene-based therapies for multiple ophthalmic diseases, the two companies announced this morning. ... Read More »

Stay grounded :: When you fly high

Stay grounded :: When you fly high Father is flying a kite. His son is watching him carefully. After some time son says “Dad. Because of the string the kite is not able to go any further higher.” Hearing this, the father smiles and breaks the string.     The kite goes higher after breaking of the thread and then ... Read More »

Novartis agrees to buy Spinifex Pharmaceuticals for more than $200m

Novartis agrees to buy Spinifex Pharmaceuticals for more than $200m Swiss drugmaker Novartis has strengthened its presence in pain management by agreeing to acquire a US-Australia biotech firm Spinifex Pharmaceuticals for more than $200m. Spinifex is focused on developing a peripheral approach to treat neuropathic pain such as EMA401, a new angiotensin II Type 2 receptor (AT2R) antagonist. EMA401 is ... Read More »

Siemens, BioNTech to develop new personalized cancer vaccines

Siemens, BioNTech to develop new personalized cancer vaccines Siemens has entered into a strategic collaboration with BioNTech for the good manufacturing practice (GMP) production of personalized cancer vaccines. Under the deal, BioNTech’s subsidiaries, BioNTech RNA Pharmaceuticals and EUFETS, will work with Siemens to build a fully automated and digitalized production site to provide capacity for BioNTech’s personalized cancer vaccines to ... Read More »

Hesitation… And why should we avoid it…

Hesitation… And why should we avoid it… Neil Armstrong, he is the 1st person to set his foot in moon. But, do you know who was supposed to be the 1st person?  Many don’t know… His name is Edwin C Aldarin… He was the pilot for the Apollo mission. He was working for the American Airforce. Moreover he had experience ... Read More »

BIGTheme.net • Free Website Templates - Downlaod Full Themes
Social Media Auto Publish Powered By : XYZScripts.com